His research focuses on ubiquitin and SUMO modification and regulation of proteins in human diseases.

Dr. Hao's clinical interests are mainly in the molecular diagnosis and classification of brain tumors.

My research has been focused on identification of cancer signaling pathway for development of pathway targeted new anticancer drugs.

Subject Area:

  • Pathology & Laboratory Medicine.
Oncology, Neurological Surgery, Pathology and Laboratory Medicine
PhD, University of Saskatchewan, 1991
MD, Beihua University, Jilin City, China, Medicine, 1985
MSc, Jilin University, Changchun, China, 1985